Adjuvant Trastuzumab Emtansine Versus Paclitaxel Plus Trastuzumab for Stage I Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 5-Year Results and Correlative Analyses From ATEMPT. - Tarantino P; Tayob N; Villacampa G; Dang C; Yardley DA; Isakoff SJ; Valero V; Faggen M; Mulvey T; Bose R; Weckstein D; Wolff AC; et al. (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024)